South Africa rejects Sputnik V over unanswered safety concerns
SAHPRA rejected Sputnik V due to unaddressed safety questions about adenovirus vectors, despite a large study showing 91% efficacy and no major safety issues elsewhere.
Herald Premium Archive
This report is for subscribers
Sign in or choose a plan for full access to every Belfast Herald story and the complete archive.
HealthSouth Africa rejects Sputnik V over unanswered safety concerns
Sign in or subscribeBrowse free archive reportsSAHPRA rejected Sputnik V due to unaddressed safety questions about adenovirus vectors, despite a large study showing 91% efficacy and no major safety issues elsewhere.